Literature DB >> 8265636

Crystal structure of murine cyclophilin C complexed with immunosuppressive drug cyclosporin A.

H Ke1, Y Zhao, F Luo, I Weissman, J Friedman.   

Abstract

Cyclophilin is a cellular receptor for the immunosuppressive drug cyclosporin A (CsA). Cyclophilin C (CyPC) is highly expressed in murine kidney, making it a potential mediator of the nephrotoxic effects of CsA. The structure of murine CyPC complexed with CsA has been solved and refined to an R factor of 0.197 at a 1.64-A resolution. Superposition of the CyPC-CsA structure with the unligated cyclophilin A (CyPA) revealed significant migration of three loops: Gln-179 to Thr-189, Asp-47 to Lys-49, and Met-170 to Ile-176. The proximity of the loop Gln-179 to Thr-189 to the CsA binding site may account for the unique binding of a 77-kDa glycoprotein, CyPC binding protein (CyCAP), to CyPC. The binding of CsA to CyPC is similar to that of CsA to human T-cell cyclophilin A (CyPA). However, the conformation of CsA when bound to CyPC is significantly different from that when bound to CyPA. These differences may reflect conformational variation of CsA when bound to different proteins. Alternatively, the previous CyPA-CsA structure at low resolution may not provide sufficient details for a comparison with the CyPC-CsA structure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8265636      PMCID: PMC48082          DOI: 10.1073/pnas.90.24.11850

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation.

Authors:  B Brenner; C W Francis; S Totterman; C M Kessler; A K Rao; R Rubin; H C Kwaan; K R Gabriel; V J Marder
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

Review 2.  Calcineurin.

Authors:  C B Klee; G F Draetta; M J Hubbard
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

3.  Crystal structure of cyclophilin A complexed with substrate Ala-Pro suggests a solvent-assisted mechanism of cis-trans isomerization.

Authors:  H Ke; D Mayrose; W Cao
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 4.  Issues in the pathophysiology of nephrotoxic renal tubular cell injury pertinent to understanding cyclosporine nephrotoxicity.

Authors:  J M Weinberg
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

Review 5.  Pathogenetic mechanisms of nephrotoxicity: insights into cyclosporine nephrotoxicity.

Authors:  H D Humes; N M Jackson; R P O'Connor; D A Hunt; M D White
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

6.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

7.  Cyclophilin: distribution and variant properties in normal and neoplastic tissues.

Authors:  A J Koletsky; M W Harding; R E Handschumacher
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

8.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

9.  Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity.

Authors:  J Liu; M W Albers; T J Wandless; S Luan; D G Alberg; P J Belshaw; P Cohen; C MacKintosh; C B Klee; S L Schreiber
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

10.  The immunochemical distribution of cyclophilin in normal mammalian tissues.

Authors:  W H Marks; M W Harding; R Handschumacher; C Marks; M I Lorber
Journal:  Transplantation       Date:  1991-08       Impact factor: 4.939

View more
  12 in total

1.  Folding of barstar C40A/C82A/P27A and catalysis of the peptidyl-prolyl cis/trans isomerization by human cytosolic cyclophilin (Cyp18).

Authors:  R Golbik; G Fischer; A R Fersht
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

2.  A molecular dynamics study of Cyclophilin A free and in complex with the Ala-Pro dipeptide.

Authors:  Pekka Mark; Lennart Nilsson
Journal:  Eur Biophys J       Date:  2007-01-16       Impact factor: 1.733

Review 3.  Identification of HIV inhibitors guided by free energy perturbation calculations.

Authors:  Orlando Acevedo; Zandrea Ambrose; Patrick T Flaherty; Hadega Aamer; Prashi Jain; Somisetti V Sambasivarao
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Screening for genes that regulate the differentiation of human megakaryocytic lineage cells.

Authors:  Fangfang Zhu; Mingye Feng; Rahul Sinha; Jun Seita; Yasuo Mori; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-27       Impact factor: 11.205

5.  A cell-impermeable cyclosporine A derivative reduces pathology in a mouse model of allergic lung inflammation.

Authors:  Molly A Balsley; Miroslav Malesevic; Erik J Stemmy; Jason Gigley; Rosalyn A Jurjus; Dallen Herzog; Michael I Bukrinsky; Gunter Fischer; Stephanie L Constant
Journal:  J Immunol       Date:  2010-11-05       Impact factor: 5.422

6.  Delineation of the calcineurin-interacting region of cyclophilin B.

Authors:  M Carpentier; F Allain; B Haendler; M C Slomianny; G Spik
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

7.  Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.

Authors:  Feng Yang; Jason M Robotham; Heather B Nelson; Andre Irsigler; Rachael Kenworthy; Hengli Tang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

8.  Cyclophilin inhibitors as a novel HCV therapy.

Authors:  Hengli Tang
Journal:  Viruses       Date:  2010-08-05       Impact factor: 5.818

Review 9.  The cyclophilins.

Authors:  Ping Wang; Joseph Heitman
Journal:  Genome Biol       Date:  2005-06-27       Impact factor: 13.583

10.  MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2.

Authors:  Mitsuhiro Matsuo; Chisato Nakada; Yoshiyuki Tsukamoto; Tsuyoshi Noguchi; Tomohisa Uchida; Naoki Hijiya; Keiko Matsuura; Masatsugu Moriyama
Journal:  Mol Cancer       Date:  2013-02-25       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.